Literature DB >> 11867754

Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.

Shiquan Liu1, Wenjing Liu, John L Jakubczak, Gregory L Erexson, Kenneth R Tindall, Richard Chan, William J Muller, Sankar Adhya, Susan Garges, Glenn Merlino.   

Abstract

It has been argued that genetic instability is required to generate the myriad mutations that fuel tumor initiation and progression and, in fact, patients with heritable cancer susceptibility syndromes harbor defects in specific genes that normally maintain DNA integrity. However, the vast majority of human cancers arise sporadically, in the absence of deficiencies in known "mutator" genes. We used a cII-based mutation detection assay to show that the mean frequency of forward mutations in primary mammary adenocarcinomas arising in mouse mammary tumor virus-c-erbB2 transgenic mice harboring multiple copies of the lambda bacteriophage genome was significantly higher than in aged-matched, wild-type mammary tissue. Analysis of the cII mutational spectrum within the mammary tumor genomic DNA demonstrated a >6-fold elevation in transversion mutation frequency, resulting in a highly unusual inversion of the transition/transversion ratio characteristic of normal epithelium; frameshift mutation frequencies were unaltered. Arising oncogenic point mutations within the c-erbB2 transgene of such tumors were predominantly transversions as well. Data from this model system support the notion that elaboration of a mutator phenotype is a consequential event in breast cancer and suggest that a novel DNA replication/repair gene is a relatively early mutational target in c-erbB2-induced mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867754      PMCID: PMC122599          DOI: 10.1073/pnas.052710299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  A novel SMC protein complex in Schizosaccharomyces pombe contains the Rad18 DNA repair protein.

Authors:  M I Fousteri; A R Lehmann
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

2.  Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair.

Authors:  M Strand; T A Prolla; R M Liskay; T D Petes
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

3.  Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.

Authors:  C E Bronner; S M Baker; P T Morrison; G Warren; L G Smith; M K Lescoe; M Kane; C Earabino; J Lipford; A Lindblom
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

4.  Mutation of a mutL homolog in hereditary colon cancer.

Authors:  N Papadopoulos; N C Nicolaides; Y F Wei; S M Ruben; K C Carter; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser; M D Adams
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

5.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

Review 6.  Mammalian DNA mismatch repair.

Authors:  A B Buermeyer; S M Deschênes; S M Baker; R M Liskay
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

7.  Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.

Authors:  P M Siegel; D L Dankort; W R Hardy; W J Muller
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

Review 9.  The biology of erbB-2/neu/HER-2 and its role in cancer.

Authors:  N E Hynes; D F Stern
Journal:  Biochim Biophys Acta       Date:  1994-12-30

10.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

View more
  11 in total

1.  A new mutator phenotype in breast cancer?

Authors:  Johan G de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  The mutational spectrum of non-CpG DNA varies with CpG content.

Authors:  Jean-Claude Walser; Anthony V Furano
Journal:  Genome Res       Date:  2010-05-24       Impact factor: 9.043

Review 3.  Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature.

Authors:  Dimitrios Koutsimpelas; Jürgen Brieger; Ulf Heinrich; Michael Torzewski; Clemens Sommer; Wolf J Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-05       Impact factor: 2.503

4.  Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms.

Authors:  Philip A Beer; Christina A Ortmann; Frank Stegelmann; Paola Guglielmelli; John T Reilly; Thomas S Larsen; Hans C Hasselbalch; Alessandro M Vannucchi; Peter Möller; Konstanze Döhner; Anthony R Green
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

5.  Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors.

Authors:  Yong Soon Chun; Takahiro Yoshida; Tsuyoshi Mori; David L Huso; Zhe Zhang; Vered Stearns; Brandy Perkins; Richard J Jones; Saraswati Sukumar
Journal:  Breast Cancer Res Treat       Date:  2012-07-01       Impact factor: 4.872

6.  Modeling variation in tumors in vivo.

Authors:  James R Stringer; Jon S Larson; Jared M Fischer; Mario Medvedovic; Megan N Hersh; Gregory P Boivin; Saundra L Stringer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-03       Impact factor: 11.205

7.  Discriminating somatic and germline mutations in tumor DNA samples without matching normals.

Authors:  Saskia Hiltemann; Guido Jenster; Jan Trapman; Peter van der Spek; Andrew Stubbs
Journal:  Genome Res       Date:  2015-07-24       Impact factor: 9.043

8.  A comparative analysis of algorithms for somatic SNV detection in cancer.

Authors:  Nicola D Roberts; R Daniel Kortschak; Wendy T Parker; Andreas W Schreiber; Susan Branford; Hamish S Scott; Garique Glonek; David L Adelson
Journal:  Bioinformatics       Date:  2013-07-09       Impact factor: 6.937

9.  Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells.

Authors:  David W Leung; Chris Tompkins; Jim Brewer; Alexey Ball; Mike Coon; Valerie Morris; David Waggoner; Jack W Singer
Journal:  Mol Cancer       Date:  2004-05-13       Impact factor: 27.401

10.  Genomic variation between PRSV resistant transgenic SunUp and its progenitor cultivar Sunset.

Authors:  Jingping Fang; Andrew Michael Wood; Youqiang Chen; Jingjing Yue; Ray Ming
Journal:  BMC Genomics       Date:  2020-06-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.